More Trade Mark Wars on the anvil in India.


Thanks to the onset of the New IPR Regime already for Trade Marks, the TM Wars have set in on a larger scale in India as well.The latest one is between Pfizer for its erectile disfunction drug Viagra and the pedigrees such as Penegra , Silagra , Alsigra,Edegra,Kamagra, Progra and so on, reportedly about 10-odd versions with a number of them having the ‘gra’ suffix, promoted by the Indian companies such as Zydus Cadilla and Cipla. It is estimated that out of the Rs 25 crores market, Penegra contributes about Rs 2 crores.Similarly Ranbaxy has sued Wilmark Pharmaceuticals for marketing an analgesic as Fortwell having similarity with its product Fortwin.